Hong Kong: ACT Genomics opens lab in Hong Kong

Hua Chien Chen, chief executive officer of ACT Genomics delivers opening remarks in the opening ceremony.

Cancer precision treatment solution provider ACT Genomics has opened its third Next Generation Sequencing laboratory in Asia at the Hong Kong Science Park. Founded in Taiwan in 2014, ACT Genomics provides cancer patients with personalised genomic information based-treatment plans through its Next Generation Sequencing platform, medical report and integrated services. The platform is capable of…

You must be a HMI Subscriber to view this content.

Subscribe Now »